During the past decade, Investigational Drug Service conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Investigational Drug Service" #1 collaborator was "UCB Pharma" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Investigational Drug Service" are "Acute Lymphoblastic Leukemia" (1 trials), "Acute Myeloid Leukemia" (1 trials), "Advanced Breast Cancer" (1 trials), "Advanced Cancers" (1 trials) and "Advanced Gastric Cancer" (1 trials). Many other conditions were trialed in "Investigational Drug Service" in a lesser frequency.

Most popular intervention types in "Investigational Drug Service" are "Drug" (9 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Rituximab" (2 trials), "inotuzumab ozogamicin" (2 trials), "Avelumab" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Investigational Drug Service" are 6 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Investigational Drug Service". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Investigational Drug Service, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Investigational Drug Service, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".